Tag: Hatch-Waxman Act
Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Explore how the FDA approves generic drugs via the ANDA process, ensuring safety and savings. Learn about bioequivalence standards, GDUFA timelines, and the impact of the Hatch-Waxman Act on your medication.
Medications
Archives
Recent-posts
Pregnancy and Sleep: How to Manage Apnea, Reflux, and Positioning for Better Rest
Mar, 18 2026
How to Discuss Side Effects without Stopping Your Medication
Feb, 7 2026
Exploring Vibramycin Alternatives: A Look at Other Options
Mar, 20 2025
Gastritis and H. pylori: What Causes It, How It’s Treated, and What You Need to Know
Dec, 31 2025
Alternatives to Sumatriptan: Exploring the Options for Migraine Relief
Mar, 28 2025